|
|
|
| Join The Advancing RNA Community | Introducing Advancing RNA, an online community designed to be a forum and resource for professionals working on RNA-based therapeutics to better understand the challenges that confront them in areas like Analytical/Quality, Manufacturing, Formulation, Outsourcing, Clinical Research, and Supply Chain/Logistics. Sign up for the Advancing RNA newsletter, delivered to your inbox weekly. |
|
|
|
|
Our Life Science Connect sister publication, Bioprocess Online, asked Linda Pissott Reig, an attorney at Buchanan Ingersoll and Rooney, to explain more about why the FDA is focusing on safety programs for drugs with high-risk profiles and what it means for drug companies that have REMS products in their portfolios. |
|
|
|
According to the United States Court of Appeals for the Federal Circuit’s recent ruling in In re Cellect, there are certain instances where the calculation of patent term may not include patent term adjustment (PTA). |
|
|
|
Freya Biosciences is enlivening the long-time lonely space of reproductive health, starting with a new focus on the vaginal microbiome. |
|
|
|
|
|
|
|
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
| Connect With Life Science Leader: |
|
|
|
